DXCM - NASDAQ

DexCom, Inc.

DXCM·NASDAQ

$72.77

-0.93%

HealthcareMedical - Devices

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$28.08B

EPS2.1400

P/E Ratio34.00

Earnings Date07/29/2026

6.34B

Assets

-2%

3Y+18.0%

5Y+48.0%

10Y+1474.0%

3.59B

Total Liabilities

-18%

3Y+10.0%

5Y+46.0%

10Y+2920.0%

2.75B

Total Equity

31%

3Y+29.0%

5Y+50.0%

10Y+868.0%

DexCom, Inc. Funding & Solvency Profile

DXCM · NASDAQ

Current Assets

Cash & Cash Equivalents917.70M

Net Receivables1.29B

Inventory629.10M

Other Current Assets49.20M

Total Current Assets4 B

Non-Current Assets

Property, Plant & Equipment1.64B

Goodwill & Intangible Assets95.00M

Long-Term Investments218.00M

Other Non-Current Assets60.70M

Total Non-Current Assets2 B

Total Assets

6.34B

Financial Health Analysis

Current Ratio

1.88x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.31x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

2 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

64% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

DexCom, Inc. Balance Sheet

DXCM • NASDAQ

DexCom, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	917.7M	606.1M	566.3M	642.3M	1.1B	817.6M	446.2M	1.1B	441.5M	94.5M	86.1M	71.8M	43.2M	8.1M	2.6M	4.9M	3.6M	12.7M	23.1M	18.2M
Short-Term Investments	1.1B	2B	2.2B	1.8B	1.7B	1.9B	1.1B	248.6M	107.1M	29.2M	29.1M	11.8M	11.4M	40.6M	79.4M	42.2M	24.4M	14.4M	41.2M	36.3M
Cash & Short-Term Investments	2B	2.6B	2.7B	2.5B	2.7B	2.7B	1.5B	1.4B	548.6M	123.7M	115.2M	83.6M	54.6M	48.7M	81.9M	47.1M	28M	27.1M	64.3M	54.5M
Net Receivables	1.3B	1B	987.5M	752.2M	516.6M	428.5M	286.3M	226.7M	134.3M	101.7M	74.1M	42.4M	26.1M	19.5M	12.5M	6.7M	3.5M	1.1M	215K	120K
Accounts Receivables	1.2B	1B	973.9M	713.3M	514.3M	428.5M	286.3M	226.7M	134.3M	101.7M	74.1M	42.4M	26.1M	19.5M	12.5M	6.7M	3.5M	1.1M	215K	120.5K
Other Receivables	73.8M	27.9M	13.6M	38.9M	2.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	629.1M	542.6M	559.6M	306.7M	357.3M	234.7M	119.8M	70.7M	45.2M	45.4M	35.2M	16M	9M	7.4M	8.2M	8.1M	2.6M	2.4M	1.1M	1.4M
Prepaids	66.4M	87.5M	90.2M	116.7M	51.9M	53.9M	30M	16.5M	16.6M	9.2M	6.8M	3.9M	3.4M	2M	1.8M	2.7M	2.8M	1.4M	1.6M	1.3M
Other Current Assets	49.2M	58.3M	64.5M	37M	27.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	775K	0.0	0.0	0.0	1K
Total Current Assets	4B	4.3B	4.4B	3.7B	3.7B	3.4B	2B	1.7B	744.7M	280M	231.3M	145.9M	93.1M	77.6M	104.4M	66M	36.9M	32.1M	67.3M	57.4M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.6B	1.4B	1.2B	1.1B	889.9M	608.6M	392.8M	183.1M	145.6M	109.4M	54.7M	31.2M	20.7M	18.9M	15M	10.8M	6.4M	6.1M	6.6M	6.1M
Goodwill	24.2M	22.8M	25.2M	25.7M	26.5M	19.3M	18.6M	18.7M	12.1M	11.3M	3.7M	3.2M	3.2M	3.2M	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	70.8M	103.4M	134.5M	173.3M	31.5M	21.4M	0.0	0.0	0.0	200K	2.2M	2.7M	3.6M	4.2M	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	95M	126.2M	159.7M	199M	58M	40.7M	18.6M	18.7M	12.1M	11.5M	5.9M	5.9M	6.8M	7.4M	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	218M	119.3M	38.5M	19M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	295.6M	481.2M	419.4M	341.2M	290.5M	216.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	60.7M	53.7M	36.5M	28.1M	10.5M	0.0	14.2M	14.7M	1.7M	2.1M	100K	1.6M	1.9M	2.1M	1M	1M	3.6M	5.7M	3.3M	1.1M
Total Non-Current Assets	2.3B	2.2B	1.8B	1.7B	1.2B	865.7M	425.6M	216.5M	159.4M	122.8M	60.7M	38.7M	29.4M	28.4M	16.1M	11.1M	10M	12.3M	10M	7.2M
Total Assets	6.3B	6.5B	6.3B	5.4B	4.9B	4.3B	2.4B	1.9B	904.1M	402.8M	292M	184.6M	122.5M	106M	120.5M	77.2M	46.9M	44.4M	77.3M	64.6M
LIABILITIES
CURRENT LIABILITIES
Total Payables	380.2M	387.6M	326.5M	282.7M	230M	178.6M	116.3M	87.2M	53.8M	45.6M	21.1M	11.5M	5.4M	4.6M	3.5M	2.5M	2.6M	1.1M	1.5M	835K
Accounts Payable	344.3M	345.3M	276.4M	237.9M	189.4M	163.3M	102.3M	75.5M	46.7M	20M	19M	9.9M	4.2M	3.9M	2.8M	1.8M	2.6M	1.1M	1.5M	834.9K
Other Payables	35.9M	42.3M	50.1M	44.8M	40.6M	15.3M	14M	11.7M	7.1M	4.5M	2.1M	1.6M	1.2M	700K	700K	783K	0.0	0.0	0.0	0.0
Accrued Expenses	1.7B	1.3B	1.1B	705.7M	419.8M	390.2M	228.6M	132.3M	81.9M	53.4M	40.6M	24.6M	22.7M	12.5M	9M	8M	7.6M	3.5M	5.5M	3.5M
Short Term Debt	0.0	1.2B	0.0	772.6M	0.0	0.0	0.0	0.0	0.0	0.0	2.3M	2.3M	2.2M	200K	0.0	525K	900K	1.9M	1.4M	908K
Capital Lease Obligations (Current)	21.6M	22.5M	21.1M	20.5M	20.5M	16.5M	13.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	42.3M	50.1M	44.8M	40.7M	15.3M	14M	11.7M	7.1M	4.5M	2.1M	1.6M	1.2M	700K	735K	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	7.7M	8M	18.4M	10.1M	2.1M	2.2M	1.7M	2.9M	3.2M	900K	800K	700K	700K	1.4M	1.6M	3.5M	7.7M	6.4M	0.0	0.0
Other Current Liabilities	54.6M	56.1M	46.4M	47.7M	48.4M	26.6M	0.0	0.0	0.0	2.5M	2.1M	1.5M	1.1M	800K	600K	564K	0.0	2.1M	0.0	1K
Total Current Liabilities	2.1B	2.9B	1.6B	1.8B	720.8M	614.1M	360.2M	222.4M	138.9M	102.4M	66.9M	40.6M	32.1M	19.5M	14.7M	15.1M	18.8M	15M	8.4M	5.2M
NON-CURRENT LIABILITIES
Long Term Debt	1.2B	1.2B	2.4B	1.2B	2B	1.7B	1.1B	1B	327.6M	0.0	0.0	2.3M	4.6M	6.8M	0.0	0.0	45.8M	61.4M	61M	2.1B
Deferred Revenue (Non-Current)	0.0	9.5M	7.4M	19M	16.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	600K	300K	0.0	0.0	5.7M	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	4.9M	5.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	83.3M	79.9M	59.6M	44.8M	11M	26.9M	5.7M	12.7M	11.5M	9.9M	3.9M	1.5M	1.7M	2.1M	1M	1M	840K	889K	666K	377K
Total Non-Current Liabilities	1.5B	1.4B	2.6B	1.4B	2.2B	1.8B	1.2B	1B	345.8M	16.6M	3.9M	3.8M	6.3M	9.5M	1.2M	1M	46.6M	68M	61.7M	2.5M
Capital Lease Obligations	148.8M	146M	159.8M	174.7M	176.1M	172.3M	86M	7.3M	6.7M	6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	3.6B	4.4B	4.2B	3.3B	2.9B	2.5B	1.5B	1.3B	484.7M	119M	70.8M	44.4M	38.4M	29M	16M	16.2M	65.4M	83M	70.1M	7.7M
SHAREHOLDERS' EQUITY
Treasury Stock	-2.1B	-1.6B	-2.5B	-595M	-206.2M	-100M	-100M	-100M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	400K	400K	400K	400K	400K	100K	100K	100K	100K	100K	100K	100K	100K	100K	68K	62K	46K	30K	29K	28.2K
Additional Paid-In Capital	2.3B	2.1B	3.5B	2.3B	2.1B	2.1B	1.7B	1.6B	1.1B	905.7M	776.8M	638M	559.5M	522.6M	495.6M	407.4M	272.7M	192.7M	183.3M	187.2M
Retained Earnings	2.4B	1.6B	1B	479.9M	138.7M	-202.1M	-695.7M	-798.9M	-671.8M	-621M	-555.4M	-497.8M	-475.4M	-445.6M	-391.1M	-346.4M	-291.2M	-231.4M	-176.3M	-130.4M
Accumulated Other Comprehensive Income/Loss	115M	-8M	-16.7M	-11.6M	500K	3.2M	2.3M	1.5M	-2.6M	-1M	-300K	-100K	-100K	-100K	-80K	-66K	-13K	50K	13K	11.9K
Total Stockholders' Equity	2.7B	2.1B	2.1B	2.1B	2B	1.8B	882.6M	663.3M	419.4M	283.8M	221.2M	140.2M	84.1M	77M	104.5M	61M	-18.4M	-19.5M	7.1M	56.8M
Total Equity	2.7B	2.1B	2.1B	2.1B	2B	1.8B	882.6M	663.3M	419.4M	283.8M	221.2M	140.2M	84.1M	77M	104.5M	61M	-18.4M	-19.5M	7.1M	56.8M
SUMMARY
Total Liabilities & Equity	6.3B	6.5B	6.3B	5.4B	4.9B	4.3B	2.4B	1.9B	904.1M	402.8M	292M	184.6M	122.5M	106M	120.5M	77.2M	46.9M	43.9M	77.3M	64.6M
Total Investments	1.3B	2.1B	2.2B	1.8B	1.7B	1.9B	1.1B	248.6M	107.1M	29.2M	29.1M	11.8M	11.4M	40.6M	79.4M	42.2M	24.4M	14.4M	41.2M	36.3M
Total Debt	1.4B	2.6B	2.6B	2.1B	2.2B	1.8B	1.2B	1B	334.3M	6.7M	2.3M	4.6M	6.8M	7M	0.0	525K	46.7M	43.7M	62.4M	3M
Net Debt	472M	2B	2B	1.5B	1.1B	1B	713.9M	-119.4M	-107.2M	-87.8M	-83.8M	-67.2M	-36.4M	-1.1M	-2.6M	-4.4M	43.1M	31M	39.3M	-15.1M
Shares Outstanding	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220	391,190,220

SEC Filings

DXCM - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 28, 2026	May 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 15, 2026	May 14, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 15, 2026	May 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 02, 2026	February 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 12, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 12, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 07, 2026	2026	View Filing

Showing 1 to 10 of 403 filings

Related Guides

Blog Categories

Continue your DXCM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.